Somnics Health, a pioneer in next-generation sleep apnea solutions, announces the launch of iNAP Essentials, a breakthrough program giving patients access to iNAP Sleep Therapy for just $58/month over 24 months. This new initiative removes one of the biggest barriers to treatment—cost—and expands access to comfortable, mask-free therapy for patients with Obstructive Sleep Apnea (OSA).
More than 50 million Americans suffer from OSA, yet 80% remain untreated, and many who start CPAP therapy abandon it due to discomfort. The iNAP system offers a new path forward.
“The OSA treatment landscape is no longer CPAP-only. iNAP is effective, comfortable, and discreet—and now, more affordable than ever,” said Olivier Lauzeral, General Manager of Somnics Health. “With iNAP Essentials, we’re removing the affordability hurdle.”
A Smarter, Simpler Solution
iNAP is an FDA-cleared, clinically validated therapy that uses gentle negative pressure to keep the airway open during sleep—without forcing air through a mask. It works by creating a light vacuum in the oral cavity, shifting soft tissues forward and preventing obstruction.
Provider-Guided, Patient-Focused
iNAP is available by prescription only, ensuring medical oversight from a sleep specialist. Adoption is growing across VA hospitals, sleep centers, and DME providers.
“Physicians are seeing the value of iNAP in improving adherence and patient satisfaction,” Lauzeral emphasized. “When patients feel empowered, they stay engaged—and that’s the future of sleep medicine.”
Advancing Health Equity
Untreated sleep apnea increases the risk of heart disease, stroke, diabetes, and cognitive decline. Somnics Health sees iNAP Essentials not just as a product offering—but as a public health solution.
“This isn’t just about access—it’s about fairness,” said Lauzeral. “Sleep apnea is a serious condition, and we believe everyone deserves a shot at better health.”
For more information please visit, www.SomnicsHealth.com
